Generic Abortion Pill Maker Sues FDA to Protect Access (1)

April 19, 2023, 7:55 PM UTC

A generic-mifepristone maker sued the US Food and Drug Administration to protect access to the medical abortion pill amid a welter of litigation stretching from Texas to Washington.

The lawsuit by GenBioPro Inc., filed Wednesday in federal court in Maryland, comes as the US Supreme Court delayed until Friday a decision on which restrictions on the pill will remain in place after a federal judge in Texas blocked the FDA’s approval of mifepristone in a separate lawsuit.

GenBioPro makes most of the mifepristone sold in the US. It says in its suit that if the FDA is forced to ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.